Health Condition 1: null- Fatty Liver Disease
Conditions
Interventions
Intervention1: Arogyavardhinivati: Commercially available in the form of tablet given orally 250 mg twice daily for 60 days with
luke warm water
Control Intervention1: Liv 52 tablets: Commercially av
Sponsors
Dr Dasi Padmaja
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of both sexes between the aged group of 20-50 yrs. 2. Abnormal liver function test positive for Alanine transamise Test and AST. 3. After hematological investigations of lipid profile. 4. Clinically and Ultrasonography evidence of fatty liver disease.
Exclusion criteria
Exclusion criteria: 1. Infectious conditions. 2. Cirrhosis of liver. 3. Hepatitis B & C. 4. Ascites. 5. Obstructive pathologies. 6. Pregnant women/lactating women. 7. Tuberculosis . 8. Malignancies. 9. Immunodeficiency diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relief in signs and symptoms number of patients with sustained reduction in abnormal liver function tests to 50% of baseline. Timepoint: Relief in signs and symptoms number of patients with sustained reduction in abnormal liver function tests to 50% of baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| me Outcome Timepoints Change in abnormal lipid profile and fatty Liver through ultrasonography. Change in Body Mass Index.Timepoint: Treatment period :60 days Assessment :For every 15 days Active follow up :3months | — |
Countries
India
Contacts
Public ContactDr Dasi Padmaja
National Ayurveda research Institute for vector borne diseases
Outcome results
None listed